IGF-1 LR3
Also known as: Long R3 IGF-1 · Insulin-like Growth Factor 1 Long R3
A modified IGF-1 variant engineered to bypass growth-restricting transport proteins. Up to three times more potent than native IGF-1 for muscle hyperplasia.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~20–30 hours
20–50 mcg
Subcutaneous or intramuscular injection
Mechanism of Action
Directly activates IGF-1 receptors with reduced binding to IGFBPs, forcing extreme muscle cell hyperplasia, amino acid transport, and glycogen synthesis.
Key Research Areas
Frequently Asked Questions
What is IGF-1 LR3?▾
How does IGF-1 LR3 work?▾
What is the recommended dosage for IGF-1 LR3?▾
What is the half-life of IGF-1 LR3?▾
Is IGF-1 LR3 FDA approved?▾
Research Disclaimer
The information provided about IGF-1 LR3 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.